FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Amneal Recalls Contaminated Tablets

[ Price : $8.95]

Amneal Pharmaceutical recalls three lots of sulfamethoxazole/trimethoprim tablets because they may exhibit black spots on their ta...

Arvinas Files NDA for Breast Cancer Drug

[ Price : $8.95]

Arvinas files an NDA for vepdegestrant for treating patients with estrogen receptor-positive human epidermal growth factor recepto...

FDA: Draeger Recall is Class 1

[ Price : $8.95]

FDA says a Draeger recall of breathing circuit components is Class 1.

ICH M11 Technical Specification Guidance Out

[ Price : $8.95]

FDA publishes the International Council on Harmonization technical representation of its M11 guideline protocol template.

House Posts FDA Budget Mirroring Trumps Proposal

[ Price : $8.95]

The House Appropriations Committee posts FDAs budget bill for FY 2026 that mirrors the Trump Administrations budget proposal that ...

FDA Platform Technology OK for Sarepta Vector

[ Price : $8.95]

FDA grants platform technology designation to a Sarepta viral vector used in an investigational gene therapy to treat a form of mu...

New Safety-Related Hernia Mesh Label Recommendations

[ Price : $8.95]

FDA posts a draft guidance entitled Hernia Mesh Package Labeling Recommendations.

Drug Labeling Improved for Pregnant Women: FDA

[ Price : $8.95]

FDA confirms that all drugs now have updated labeling to better provide health risk information to pregnant women.

4 States Want Mifepristone REMS Ended

[ Price : $8.95]

California, Massachusetts, New Jersey, and New York ask FDA to cancel the mifepristone REMS program requirements in their states o...

Makary Pushes for Reductions in Regulatory Barriers

[ Price : $8.95]

FDA commissioner Marty Makary promises that the agency will listen to stakeholder ideas on reducing regulatory barriers and evolvi...